Moxalactam treatment of anaerobic infections in cancer patients.
Of 30 patients with predominantly anaerobic localized infections superimposed on chronic tissue damage related to trauma, ischemia, or tumor, 22 (73%) responded satisfactorily to moxalactam therapy. Moxalactam-resistant anaerobic pathogens emerged in two patients and were responsible for treatment f...
Na minha lista:
| 發表在: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology (ASM)
1982
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC183800/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6217784/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.22.4.604 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|